Stock Market Today 15.10.2025
Bristol-Myers Squibb (BMY) scored 88% under Validea’s Partha Mohanram P/B Growth Investor model, the highest among 22 strategies reviewed. Most key financial tests passed, but the stock failed the research and development to assets metric.